Files
Download Full Text (3.4 MB)
Description
Acute Myeloid Leukemia (AML) is a malignancy of the myeloid cell line. Patients diagnosed with AML, typically exhibit symptoms of neutropenia, anemia and thrombocytopenia. The diagnosis of AML is based on greater than 20 percent of myeloid cells in the bone marrow (1). Some risk factors for acquiring the disease include, but not limited to age, sex, smoking, exposure to certain chemicals, radiation, genetic predisposition and being treated with certain chemotherapeutic agents (2).
AML is frequently diagnosed among people between ages 65-74, with a current relative survival rate for AML being 28.7%. Men account for majority of these cases, at a rate of 5.2 per 100,000 persons compared to 3.6 per 100,000 persons for female patients (3).
Our study will assess whether treatment for AML patients has improved after 2015 with the utilization of novel chemotherapeutic agents, particularly for Beaumont Hospital patients.
Publication Date
5-2023
Keywords
Acute Myeloid Leukemia
Disciplines
Hematology | Oncology
Recommended Citation
Gbadebo D, Anusim N, Jaiyesimi I. Demographics and survival in AML patients over 60 years of age. a single institutional analysis. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2023 May; Rochester Hills, MI.
Comments
The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2023